Cheniere Energy Partners LP

▲ Bull Case

• ◆SPA extensions confirmed at higher rates (2028–2030): 2–3 major customers exercise 10-year extension options at $3.50–4.50/MMBtu (economically attractive vs. $5–6/MMBtu new-build alternatives). Implied EBITDA step-up $400–700M/year. Re-rates unit to 11–12x EV/EBITDA → $80–85/unit.
• ◆Cheniere parent drops down Stage 5 assets (1–2 trains, ~6–10 MTPA) to CQP in MLP-accretive transaction. Adds $500–900M EBITDA, pivots CQP from wasting-asset narrative to growth story. Re-rates 20–30% → $78–88/unit.
• ◆Deleveraging accelerates ahead of consensus (Net Debt/EBITDA <2.5x by FY28). Combined with cycle-driven variable distribution upside, distribution rises to $5.00–5.30/unit by FY28. Yield compression to 5.0–5.5% vs. current 7.4% → $95–100/unit at extreme bull case.

▼ Bear Case

• ◆One major SPA customer signals non-renewal (2028–2030): KOGAS or Naturgy communicates non-renewal intent. 3.5 MTPA shifts to spot exposure post-2035. EBITDA recurring impact –$300–400M. Distribution cut to $3.20–3.50. Unit re-rates to $42–48.
• ◆Sustained higher-for-longer rates (US 10Y >5.5%) hit the 2027–2030 refinancing window. $5B refinancing at 7%+ vs. existing 5.5% blended adds $75–125M annual interest. DCF/unit compresses by $0.15–0.25. Unit caps at $50–55.
• ◆LNG export policy reversal (post-2028 administration reimposes DOE pause + restricts affiliate cargo authorizations). Cheniere Marketing spot volumes cap, variable distribution upside evaporates. Combined with MLP structural discount, unit compresses to $50–55.

“The analyst debate is fundamentally about the value of the post-SPA terminal (2035+). Both bulls and bears agree on contracted period economics (~$2.6–3.0B annual DCF, $4.00–4.50 distribution, 1.40x+ coverage). Disagreement centers on terminal multiple at SPA expiration. Consensus tilts skeptical (Moderate Sell tilt, $56–60 median target), treating CQP as a wasting asset with 3.5–4.0x EV/EBITDA terminal value, giving no credit for SPA extension or Stage 5 drop-down optionality. The variant view is that the market under-prices both SPA extension economics (60–100% premium vs. new-build alternatives) and Stage 5 drop-down optionality. Even modest credit for these pushes fair value above consensus. The crystallizing event is the first SPA extension announcement (likely Shell or KOGAS), expected 2028–2030.”

• ◆Q2–Q3 2026 operating margin normalization (3–6 months, 80% probability): validates margin recovery thesis, +5–8% upside
• ◆FY26 DCF guidance reaffirmation (Q3 2026, 70% probability): confirms distribution sustainability
• ◆First SPA extension announcement (2028–2030, 60% probability): major re-rating event, +15–25% upside
• ◆Stage 5 partial drop-down to CQP (2026–2030, 20% probability): growth catalyst, +30–50% upside
• ◆Variable distribution FY26 top-up (Q1 2027, 65% probability): cycle strength gauge
• ◆Net Debt/EBITDA inflection to <3.0x (FY27, 75% probability): IG re-rating support

• ◆SPA non-renewal by 1–3 customers (15–25% probability, 2030+ timing): -15–25% unit price impact
• ◆US LNG export policy reversal (20% probability, election cycles): -5–10% impact
• ◆Henry Hub sustained >$5/MMBtu (25%/year probability, rolling): -3–5% impact via margin compression
• ◆Interest rate >5.5% sustained into 2027–2030 (30% probability, refi window): -5–7% impact
• ◆Sabine Pass operational disruption >90 days (5–10%/year probability, hurricane season): -3–5% impact
• ◆Energy-transition demand destruction (low near-term, high long-term 2035+): structural tail risk